Toronto Dominion Bank’s Estrella Immunopharma Warrant ESLAW Stock Holding History

Toronto Dominion Bank’s Portfolio ESLAW Stock Details ESLAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.62K	Hold	21,635	–	–	﹤0.01%	2009
2025 Q4	$1.08K	Sell	21,635 -14,180	-40%	-$1.47K	﹤0.01%	1932
2025 Q3	$1.86K	Hold	35,815	–	–	﹤0.01%	1823
2025 Q2	$1.7K	Buy	+35,815	New	+$1.8K	﹤0.01%	1697

Other funds holding ESLAW

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

RSWM

Robertson Stephens Wealth Management San Francisco, California $4.06B AUM 32.22% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

SIA

SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return

Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Toronto Dominion Bank's ESLAW Position: Q1 2026 in Review

Toronto Dominion Bank held its Estrella Immunopharma Warrant (ESLAW) position steady in Q1 2026 at 21,635 shares worth $1.62K. The position accounts for ﹤0.01% of the portfolio, ranked #2009.

Toronto Dominion Bank first reported a position in ESLAW in Q2 2025 and has held it in 4 quarters since. The position peaked at $1.86K in Q3 2025. 8 funds tracked by Wall St. Rank hold ESLAW as of Q1 2026.

Toronto Dominion Bank held 21,635 shares of Estrella Immunopharma Warrant worth $1.62K as of Q1 2026.
Toronto Dominion Bank left its Estrella Immunopharma Warrant share count unchanged in Q1 2026.
Estrella Immunopharma Warrant made up ﹤0.01% of Toronto Dominion Bank's portfolio in Q1 2026, its #2009 holding.
Toronto Dominion Bank first reported a position in Estrella Immunopharma Warrant in Q2 2025 and has held it in 4 quarters since.
Toronto Dominion Bank's Estrella Immunopharma Warrant position peaked at $1.86K in Q3 2025.
8 funds tracked by Wall St. Rank held Estrella Immunopharma Warrant as of Q1 2026.

Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.